CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Fagron NV Company Snapshot
Fagron NV operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fagron NV with three other pharmaceutical manufacturers in Europe: Dechra Pharmaceuticals PLC of UNITED KINGDOM (2019 sales of £481.80 million [US$589.72 million] of which 63% was European Pharmaceuticals), Boiron SA of FRANCE (557.12 million Euros [US$611.55 million] ), and Evotec SE which is based in GERMANY (446.44 million Euros [US$490.05 million] of which 76% was EVT Execute).

Sales Analysis. During the year ended December of 2019, sales at Fagron NV were 534.70 million Euro (US$586.93 million). This is an increase of 13.4% versus 2018, when the company's sales were 471.68 million Euro. This was the third consecutive year of growth at Fagron NV.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Fagron NV
  Stock Performance Chart for Fagron NV
 
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 17.30
(Figures in Euros )
1 Week 11.0%   13 Weeks -9.1%  
4 Weeks -9.9%   52 Weeks 8.1%  
 
Fagron NV Key Data:
  Ticker: FAGR Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 534,695,000
(Year Ending Jan 2020).
Employees: 2,488
  Currency: Euros Market Cap: 1,246,902,292
  Fiscal Yr Ends: December Shares Outstanding: 72,075,277
  Share Type: Parts Sociales Closely Held Shares: 16,814,179
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.